Patent · US Expired

Method to enhance an immune response of nucleic acid vaccination

US6500432B1 · kind B1 · utility

43Cited by

1References

2Claims

0Family size

Assignee

SmithKline Beecham Biologicals S.A. · BE

Inventors

Wilfried Dalemans · Leuven, BE
Marcelle Paulette Van Mechelen · Rixensart, BE
Claudine Bruck · Rixensart, BE
Martin Friede · Nyon, CH

Key dates

Filing date	Jun 12, 2000
Grant date	Dec 31, 2002
Priority date	—
Expiry date	Jun 12, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18534
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides a method to enhance an immune response of nucleic acid vaccination by simultaneous administration of a polynucleotide and a polypeptide of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.